Meeting to be held on April 8-10 hosted by Oppenheimer.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KALA:
- KALA BIO Advances Eye Disease Therapies with New Funding
- Kala Pharmaceuticals reports Q4 EPS ($1.74) vs. ($3.18) last year
- Kala Pharmaceuticals sees cash runway into 1Q26
- KALA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Kala announces resignation of CEO Iwicki, Bazemore appointed interim CEO